Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001209191-17-041627

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KARBE FRANK Director 2017-06-21 Grant or award · Stock Option (Right to Buy) +22,000 22,000 D
Loading xslF345X03/doc4.xml…